http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#Head http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#assertion http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#provenance http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#pubinfo http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#assertion http://purl.obolibrary.org/obo/DOID_2965 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_2965 http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00788 http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#association http://www.w3.org/2000/01/rdf-schema#label carefully consider the potential benefits and risks of naprosyn ec naprosyn anaprox anaprox ds or naprosyn suspension and other treatment options before deciding to use naprosyn ec naprosyn anaprox anaprox ds or naprosyn suspension use the lowest effective dose for the shortest duration consistent with individual patient treatment goals see warnings naproxen as naprosyn ec naprosyn anaprox anaprox ds or naprosyn suspension is indicated for the relief of the signs and symptoms of rheumatoid arthritis for the relief of the signs and symptoms of osteoarthritis for the relief of the signs and symptoms of ankylosing spondylitis for the relief of the signs and symptoms of juvenile arthritis naproxen as naprosyn suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient s weight naproxen as naprosyn anaprox anaprox ds and naprosyn suspension is also indicated for relief of the signs and symptoms of tendonitis for relief of the signs and symptoms of bursitis for relief of the signs and symptoms of acute gout for the management of pain for the management of primary dysmenorrhea ec naprosyn is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen containing products see clinical pharmacology dosage and administration http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/SymptomaticReliefIndication https://identifiers.org/drugbank:DB00788 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#provenance http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#pubinfo http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#sig http://purl.org/nanopub/x/hasSignature g77viwfcDTiUz9FrF8grw9me7GrDPPr4KmaO0s9NBkHDVDV8iOVSOSi5NQrlb2xP8D8DcFvYc9gyohzk6lEUhw4/8K88RWz2r4Zy3TaKIf2SDdynL/KIGn1NgMNxyuFRFbKUn4gULT8s2Y9bUsVv5DQKnxkB+tXsgvM8f8I830Q= http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo http://purl.org/dc/terms/created 2021-06-27T21:07:02.641+02:00 http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs